Stay updated on Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for STARVE-PC is displayed, describing a completed phase 2 study of nivolumab and ipilimumab, with or without enzalutamide, for AR-V7-expressing metastatic prostate cancer. The record includes participant eligibility, treatment arms, outcome measures, investigators, publications, and study documents.
    Difference
    64%
    Check dated 2026-11-10T13:58:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer shows a newer site revision number, while the page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-03T14:58:01.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-20T14:00:21.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T14:34:28.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previously visible study record content. This blocks access to the study overview, eligibility details, and contacts on the ClinicalTrials.gov record.
    Difference
    21%
    Check dated 2026-09-22T21:49:21.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision 3.7.0 replaces 3.6.6 for the page, signaling a new version of the page's documentation. It represents a maintenance update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T21:54:39.000Z thumbnail image

Stay in the know with updates to Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page.